BCL2 and cancer: BH3 profiling is a technique that identifies the BCL-2 protein family addictions of cancer cells based on the selective binding of BH3 proteins to specific anti-apoptotic BCL-2 family proteins (Certo et al., 2006, Chonghaile et al., 2014, Pan et al., 2014).